Magnetic surgery: a new tool against obesity and diabetes?

NCT ID NCT06613711

Completed Disease control Sponsor: GT Metabolic Solutions, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new magnetic device (MagDI System) that creates a connection between two parts of the small intestine without staples or stitches. The goal was to help adults with obesity and type 2 diabetes lose weight and control blood sugar. Twenty-seven participants received the procedure to see if it was safe and worked as intended.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Magnetic compression anastomosis device (MagDI System)
What this could lead to: If successful, this device could offer a less invasive surgical option for weight loss and diabetes control without traditional stapling or cutting.
What could go wrong: This is a small, early feasibility study (27 participants) with no control group. The device may fail to create a lasting connection or cause serious complications like bowel perforation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANASTOMOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANASTOMOSIS OBESITY TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Locations

Maria Cecilia Hispital

Cotignola, Italy
Ospedale Evangelco Betania

Naples, Italy
Policlinico San Marco

Bergamo, Italy
San Raffaelle Hospital

Milan, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.